Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADK |
| Upstream (Parents) |
|---|
| (<<) EHHADH → ADK |
| (<<) ACADSB → ADK |
| (<<) ETFB → ADK |
| (<<) HSDL2 → ADK |
| (<<) ISOC1 → ADK |
| Downstream (Children) |
|---|
| ADK → TH (>>) |
| ADK → SEMG2 (>>) |
| ADK → CELSR1 (>>) |
| ADK → CA7 (>>) |
| ADK → ALPK3 (>>) |
| ADK → NDRG2 (>>) |
| ADK → OR2S2 (>>) |
| ADK → VPS53 (>>) |
| ADK → TOP3B (>>) |
| ADK → MT3 (>>) |
| ADK → CARD10 (>>) |
| ADK → C22orf24 (>>) |
| ADK → PKD1 (>>) |
| ADK → RAGE (>>) |
| ADK → ABHD3 (>>) |
| ADK → NMT2 (>>) |
| ADK → SLC15A2 (>>) |
| ADK → MEFV (>>) |
| ADK → UBC///UBB///RPS27A (>>) |
| ADK → PSG6 (>>) |
